| Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure–function relation to therapeutic inhibition G Tibolla, GD Norata, R Artali, F Meneghetti, AL Catapano Nutrition, metabolism and cardiovascular diseases 21 (11), 835-843, 2011 | 171 | 2011 |
| Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles GD Norata, K Garlaschelli, L Grigore, S Raselli, S Tramontana, ... Atherosclerosis 208 (1), 177-182, 2010 | 102 | 2010 |
| A molecular dynamics study of human serum albumin binding sites R Artali, G Bombieri, L Calabi, A Del Pra Il Farmaco 60 (6-7), 485-495, 2005 | 85 | 2005 |
| An analytical and theoretical approach for the profiling of the antioxidant activity of essential oils: the case of Rosmarinus officinalis L. G Beretta, R Artali, RM Facino, F Gelmini Journal of Pharmaceutical and Biomedical Analysis 55 (5), 1255-1264, 2011 | 75 | 2011 |
| Quinoline alkaloids in honey: further analytical (HPLC-DAD-ESI-MS, multidimensional diffusion-ordered NMR spectroscopy), theoretical and chemometric studies G Beretta, R Artali, E Caneva, S Orlandini, M Centini, RM Facino Journal of Pharmaceutical and Biomedical Analysis 50 (3), 432-439, 2009 | 67 | 2009 |
| Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents R Cincinelli, L Musso, S Dallavalle, R Artali, S Tinelli, D Colangelo, ... European journal of medicinal chemistry 63, 387-400, 2013 | 62 | 2013 |
| Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes B Tasso, C Canu Boido, E Terranova, C Gotti, L Riganti, F Clementi, ... Journal of medicinal chemistry 52 (14), 4345-4357, 2009 | 58 | 2009 |
| Nemorubicin and doxorubicin bind the G-quadruplex sequences of the human telomeres and of the c-MYC promoter element Pu22 L Scaglioni, R Mondelli, R Artali, FR Sirtori, S Mazzini Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (6), 1129-1138, 2016 | 53 | 2016 |
| 7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors R Cincinelli, L Musso, L Merlini, G Giannini, L Vesci, FM Milazzo, ... Bioorganic & Medicinal Chemistry 22 (3), 1089-1103, 2014 | 53 | 2014 |
| Molecular docking of opiates and opioid peptides, a tool for the design of selective agonists and antagonists, and for the investigation of atypical ligand-receptor interactions L Gentilucci, A Tolomelli, R De Marco, R Artali Current medicinal chemistry 19 (11), 1587-1601, 2012 | 39 | 2012 |
| Green tea catechins in chemoprevention of cancer: a molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1) R Artali, G Beretta, P Morazzoni, E Bombardelli, F Meneghetti Journal of enzyme inhibition and medicinal chemistry 24 (1), 287-295, 2009 | 38 | 2009 |
| Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold G Giannini, G Battistuzzi, L Vesci, FM Milazzo, F De Paolis, M Barbarino, ... Bioorganic & medicinal chemistry letters 24 (2), 462-466, 2014 | 36 | 2014 |
| Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno [2, 1-b] phenanthrene analogue of Lamellarin D S Cananzi, L Merlini, R Artali, GL Beretta, N Zaffaroni, S Dallavalle Bioorganic & medicinal chemistry 19 (16), 4971-4984, 2011 | 36 | 2011 |
| Investigation of the interaction between the atypical agonist c [YpwFG] and MOR L Gentilucci, F Squassabia, R Demarco, R Artali, G Cardillo, A Tolomelli, ... The FEBS Journal 275 (9), 2315-2337, 2008 | 36 | 2008 |
| Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors R Cincinelli, L Musso, R Artali, M Guglielmi, E Bianchino, F Cardile, ... European journal of medicinal chemistry 143, 2005-2014, 2018 | 35 | 2018 |
| Structure and stability of human telomeric G-quadruplex with preclinical 9-amino acridines R Ferreira, R Artali, A Benoit, R Gargallo, R Eritja, DM Ferguson, ... PloS one 8 (3), e57701, 2013 | 35 | 2013 |
| Adsorption of human serum albumin on the chrysotile surface: a molecular dynamics and spectroscopic investigation R Artali, AD Pra, E Foresti, IG Lesci, N Roveri, P Sabatino Journal of the Royal Society Interface 5 (20), 273-283, 2008 | 35 | 2008 |
| Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study S Mazzini, L Musso, S Dallavalle, R Artali Molecules 25 (16), 3745, 2020 | 34 | 2020 |
| c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical approach L Musso, S Mazzini, A Rossini, L Castagnoli, L Scaglioni, R Artali, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (3), 615-629, 2018 | 34 | 2018 |
| The Inverse Type II β‐Turn on D‐Trp‐Phe, a Pharmacophoric Motif for MOR Agonists L Gentilucci, A Tolomelli, R De Marco, S Spampinato, A Bedini, R Artali ChemMedChem 6 (9), 1640-1653, 2011 | 34 | 2011 |
Luca GentilucciDept. of Chemistry "G. Ciamician" University of BolognaVerified email at unibo.it
